Concepedia

Author

Nabil Al‐Tawil

Karolinska University Hospital

Also Known As

N Al-Tawil, N. Al-Tawil, N. G. AL‐TAWIL, N.G. Al-Tawil, Nabil AL-Tawil, Nabil Al-Tawil, Nabil Al‐Tawil, Nabil G. Al‐Tawil, Nabil al-Tawil

28

Publications

687

Citations

12

H-Index

36

Concepts

All Affiliations

Karolinska University HospitalKarolinska InstitutetCHDI FoundationUniversité de LilleInstitut Pasteur de Lille
NA

About

Nabil Al‐Tawil is an author at Karolinska University Hospital specializing in medicine, positron emission tomography, and neurology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

327

2

Health Sciences

2

2

113

3

Engineering

1

1

82

4

Biomedical Engineering

1

1

38

5

Global Health

1

1

13

Nabil Al‐Tawil

×

15

Publications

642

Citations

12

H-Index

YearCitations

A Phase I Clinical Study of a Live Attenuated Bordetella pertussis Vaccine - BPZE1; A Single Centre, Double-Blind, Placebo-Controlled, Dose-Escalating Study of BPZE1 Given Intranasally to Healthy Adult Male Volunteers

Rigmor Thorstensson, Birger Trollfors, Nabil Al‐Tawil,

PLoS ONE

2014

139

In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients

Andrea Varrone, Patrik Mattsson, Anton Forsberg,

European Journal of Nuclear Medicine and Molecular Imaging

2013

82

Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects

Andrea Varrone, Vesa Oikonen, Anton Forsberg,

European Journal of Nuclear Medicine and Molecular Imaging

2014

77

Pharmacokinetics of transdermal buprenorphine patch in the elderly

Nabil Al‐Tawil, Ingegerd Odar‐Cederlöf, Anna-Carin Berggren,

European Journal of Clinical Pharmacology

2012

58

Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study

Maja Jahnmatz, Laura Richert, Nabil Al‐Tawil,

The Lancet Infectious Diseases

2020

53

PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression

Patrik Fazio, Cheryl Fitzer‐Attas, Ladislav Mrzljak,

Movement Disorders

2020

39

Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial

Theresa Neimert-Andersson, Jonas Binnmyr, Mattias Enoksson,

Vaccine

2014

38

In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects

Marielle Delnomdedieu, Anton Forsberg, Adam Ogden,

Neuropharmacology

2017

36

Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D 2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18 F-MNI-659 and 11 C-raclopride with correction for partial volume effect

Patrik Fazio, Martin Schain, Ladislav Mrzljak,

NeuroImage

2017

28

Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline

Stefan Sturm, Anton Forsberg, Stephane Navé,

European Journal of Nuclear Medicine and Molecular Imaging

2016

25

Page 1